BMO Capital Reiterates Buy Rating on Healthpeak Properties
BMO Capital maintains its buy rating for Healthpeak Properties with a $24 target.
Key Points
- BMO Capital reiterated its buy rating on Healthpeak Properties, setting a price target of $24 on June 15, 2026.
- Healthpeak Properties, trading at $20.69, has a market cap of $14.26 billion and a P/E ratio of 64.66.
- Insiders and institutions have been active, with notable trades and analyst ratings reflecting continued interest in the stock.
BMO Capital reiterated its buy rating on Healthpeak Properties, Inc. (NYSE:DOC) on June 15, 2026, setting a price target of $24. Analyst Juan Sanabria reaffirmed the positive outlook, as shares recently traded at $20.69.
Healthpeak Properties Stock Snapshot
Shares of NYSE:DOC are trading near $20.69. Healthpeak Properties has a market cap of approximately $14.26 billion and a P/E ratio of 64.66. The stock's 52-week range has been between $15.70 and $20.82, with a 50-day moving average of $18.27 and a 200-day moving average of $17.72. The company has a current ratio of 2.04 and a quick ratio of 1.41, with a debt-to-equity ratio of 118.24.
Recent Earnings
Healthpeak Properties reported revenue of $2.87 billion, reflecting a growth of 7.1%. The company has a net margin of 7.73% and a return on equity of 2.8%. Earnings per share stand at $0.32. The next earnings report is scheduled for July 23, 2026.
Dividend
Healthpeak Properties offers an annual dividend rate of $1.22, yielding 5.9%. The dividend payout ratio is 381.26%.
Insider Buying and Selling at Healthpeak Properties, Inc.
Recent insider activity includes EVP and Treasurer Ankit Patadia buying 1,358 shares at $15.46 and selling 94 shares at $19.15 on May 29, 2026. CFO Kelvin Moses also bought 937 shares at $15.46. President and CEO Scott Brinker sold 114 shares at $19.15 the same day.
Analysts Set New Price Targets
On June 15, 2026, BMO Capital maintained its buy rating on Healthpeak Properties with a $24 price target. Morgan Stanley downgraded the stock to hold with a $22 target on June 11, 2026. Wells Fargo and Scotiabank both maintained hold ratings with targets of $20 and $21, respectively. The consensus among 18 analysts is a buy rating with a mean target price of $21.06.
Other Institutional Activity in Healthpeak Properties
BlackRock, Inc. slightly reduced its position by 182,068 shares, ending with 73,360,519 shares valued at about $1.21 billion. Vanguard Portfolio Management LLC holds 58,125,899 shares worth approximately $955.01 million. State Street Corp trimmed its holdings by 872,866 shares, retaining 48,500,600 shares valued at $796.86 million. Meanwhile, JPMorgan Chase & Co increased its stake by 14,056,729 shares to a total of 44,731,541 shares, worth around $740.31 million.
About Healthpeak Properties
Healthpeak Properties, Inc. is a leading real estate investment trust (REIT) focused on healthcare facilities. Headquartered in Denver, Colorado, the company owns and operates properties across the United States. Healthpeak's portfolio includes outpatient medical, lab, and continuing care retirement communities. The company, led by CEO Scott M. Brinker, employs over 400 people and is part of the S&P 500 index.
Bottom Line
BMO Capital's reiterated buy rating on Healthpeak Properties underscores continued confidence in the company's performance. With a solid market presence and a diverse portfolio, Healthpeak remains a key player in the healthcare real estate sector. Investors often track such analyst ratings as they reflect professional assessments of a company's future potential.
See Also
This instant news alert was generated by automated narrative technology and financial data from EarningsIQ and public regulatory filings. It is for informational purposes only and is not financial advice.